TEMPO trial: Trauma-focused Exposure with Motion for Posttraumatic stress disorder
- Conditions
- Posttraumatic Stress DisorderPTSD10002861
- Registration Number
- NL-OMON53394
- Lead Sponsor
- GGZ Drenthe (Assen)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 182
1) PTSD diagnosis established by the Clinician-Administered PTSD scale for
DSM-5 (CAPS-5)
2) age 18 years or older
3) sufficient mastery of the Dutch language to perform the assessments
4) be able to keep a stable dose of psychotropic medication between four weeks
before entering the trial and until the first follow-up assessment, three
months post treatment (F4).
1) unable to walk for approximately one hour
2) a high acute risk of suicidality
3) hospitalized in the past three months due to severe psychiatric conditions
(e.g., severe self-injury, acute florid psychotic symptoms or severe eating
disorder
4) report high levels of acute dissociative amnesia (memory gaps) which might
prevent them to store new, corrective information from the trauma-focused
treatment session
5) severe substance use disorder which needs specialized treatment
6) uses substances and cannot adhere to the agreement of not being under the
influence of addictive substances during treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome parameter is PTSD severity over time, measured with<br /><br>Clinical-Administered PTSD Scale for DSM-5 (CAPS-5).</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcome parameters are trauma-related avoidance and general avoidance<br /><br>tendencies. Moreover, self-reported PTSD symptoms, depressive- and dissociative<br /><br>symptoms, treatment expectancy and engagement, and heart and respiration rate<br /><br>during VR exposure sessions will be measured.</p><br>